162 related articles for article (PubMed ID: 25524945)
1. The identification and characterization of a STAT5 gene signature in hematologic malignancies.
Sonkin D; Palmer M; Rong X; Horrigan K; Regnier CH; Fanton C; Holash J; Pinzon-Ortiz M; Squires M; Sirulnik A; Radimerski T; Schlegel R; Morrissey M; Cao ZA
Cancer Biomark; 2015; 15(1):79-87. PubMed ID: 25524945
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract][Full Text] [Related]
4. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
[TBL] [Abstract][Full Text] [Related]
5. JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.
Springuel L; Renauld JC; Knoops L
Haematologica; 2015 Oct; 100(10):1240-53. PubMed ID: 26432382
[TBL] [Abstract][Full Text] [Related]
6. JAK/STAT5 signaling pathway inhibitor ruxolitinib reduces airway inflammation of neutrophilic asthma in mice model.
Li RF; Wang GF
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):835-843. PubMed ID: 29461617
[TBL] [Abstract][Full Text] [Related]
7. [Activation of JAK/STAT in ovarian high-grade serous cancers and its prognostic significance].
Yang J; DU J; Wang YX; Liu CR
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):270-275. PubMed ID: 37042137
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.
Recio C; Guerra B; Guerra-Rodríguez M; Aranda-Tavío H; Martín-Rodríguez P; de Mirecki-Garrido M; Brito-Casillas Y; García-Castellano JM; Estévez-Braun A; Fernández-Pérez L
Oncogene; 2019 Jun; 38(24):4657-4668. PubMed ID: 30783189
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate Is a JAK/STAT Pathway Inhibitor.
Thomas S; Fisher KH; Snowden JA; Danson SJ; Brown S; Zeidler MP
PLoS One; 2015; 10(7):e0130078. PubMed ID: 26131691
[TBL] [Abstract][Full Text] [Related]
11. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
12. Jak/Stat pathway in Waldenström's macroglobulinemia.
Hodge LS; Ansell SM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):112-4. PubMed ID: 21454207
[TBL] [Abstract][Full Text] [Related]
13. pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms.
Sakr H; Clark Schneider K; Murugesan G; Bodo J; Hsi ED; Cook JR
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):147-152. PubMed ID: 27258562
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies.
Mughal TI; Girnius S; Rosen ST; Kumar S; Wiestner A; Abdel-Wahab O; Kiladjian JJ; Wilson WH; Van Etten RA
Leuk Lymphoma; 2014 Sep; 55(9):1968-79. PubMed ID: 24206094
[TBL] [Abstract][Full Text] [Related]
15. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
Wingelhofer B; Neubauer HA; Valent P; Han X; Constantinescu SN; Gunning PT; Müller M; Moriggl R
Leukemia; 2018 Aug; 32(8):1713-1726. PubMed ID: 29728695
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells.
Sandoval-Usme MC; Umaña-Pérez A; Guerra B; Hernández-Perera O; García-Castellano JM; Fernández-Pérez L; Sánchez-Gómez M
PLoS One; 2014; 9(1):e87769. PubMed ID: 24489959
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation.
Jin X; Ng V; Zhao M; Liu L; Higashimoto T; Lee ZH; Chung J; Chen V; Ney G; Kandarpa M; Talpaz M; Li Q
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35352806
[TBL] [Abstract][Full Text] [Related]
19. Analysis of hematopathology and alteration of JAK1/STAT3/STAT5 signaling axis in experimental myelodysplastic syndrome.
Daw S; Chatterjee R; Law A; Law S
Chem Biol Interact; 2016 Dec; 260():176-185. PubMed ID: 27725143
[TBL] [Abstract][Full Text] [Related]
20. The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling.
Michl C; Vivarelli F; Weigl J; De Nicola GR; Canistro D; Paolini M; Iori R; Rascle A
PLoS One; 2016; 11(6):e0157430. PubMed ID: 27304884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]